This is the authors' abstract. We don't add key points for this paper.
Non-alcoholic fatty liver disease (NAFLD) has been identified as the instigator of systemic reactive oxygen species (ROS) synthesis, and lipotoxicity which potentiate chronic kidney disease (CKD) through dysregulated redox homeostasis, and pathways of cell death. This research investigates the renoprotective effect of low-molecular-weight bioactive peptides derived from the by-products of whiteleg shrimp on high-fat diet (HFD)-induced NAFLD nephrotoxicity in male Wistar rats. Protein hydrolysates were produced by enzymatic hydrolysis and the molecular weight distribution showed 79% of the sample in a fraction <500 Da. Twenty-four male rats were divided to control, HFD, HFD+20 and 300 mg hydrolysates/kg BW groups for 70 days. Oxidative stress (total oxidant status [TOS], malondialdehyde [MDA], total antioxidant capacity [TAC], catalase [CAT]), gene expression (qRT-PCR) for autophagy factors: Beclin-1, LC3-I, Atg7 p62; apoptosis: Bax, Bcl-2, Caspase-3 and cell cycle p53 and p21 were determined from renal tissues along with histopathological studies (H&E pyknotic nuclei). The results indicated that HFD increased TOS/MDA levels, downregulated autophagy genes (Beclin-1, Atg7) and upregulated pro-apoptotic markers (Bax, Caspase-3, p53, p21), which resulted in tubular degeneration and inflammation. Hydrolysates supplementation mitigated ROS-induced oxidative damage in a dose-dependent manner (decreased TOS/MDA, enhanced CAT), restored autophagic flux (increased Beclin-1/Atg7/p62), normalized the Bax/Bcl-2 ratio, and inhibited apoptosis, particularly with 20 mg/kg yielding nearly complete histologic protection. These results reveal that shrimp hydrolysates provide the capacity to regulate redox and rescue the renal autophagy flux and p53-mediated apoptosis in metabolic lipotoxicity, so they could be repurposed as sustainable therapeutics against NAFLD-associated CKD.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Barazesh et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: